Habibian, M. and Dehghani, M. (2018) “Out-of-pocket costs analysis of ifosfamide, epirubicin, and etoposide (IEV) and etoposide, solu-medrol-methylprednisolone, high-dose ara-C-cytarabine, and platinol-cisplatin (ESHAP) regimens in the patients with relapsed and refractory lymphoma in Iran”, Chronic Diseases Journal, 6(2), pp. 87–92. doi: 10.22122/cdj.v6i2.270.